1. |
Llovet JM, Fuster J, Bruix J. Intentiontotreat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation [J]. Hepatology, 1999, 30(6): 14341440.
|
2. |
Choi GH, Kim DH, Kang CM, et al. Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma? [J]. World J Surg, 2007, 31(12): 23702377.
|
3. |
Chen XP, Hu DY, Zhang ZW, et al. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma [J]. Dig Surg, 2007, 24(3): 208213..
|
4. |
Chau GY, Lui WY, Tsay SH, et al. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a casecontrol study [J]. Ann Surg Oncol, 2006, 13(10): 13291337.
|
5. |
Marelli L, Stigliano R, Triantos C, et al. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies [J]. Cancer Treat Rev, 2006, 32(8): 594606.
|
6. |
Jeong S, Aikata H, Katamura Y, et al. Lowdose intermittent interferonalpha therapy for HCVrelated liver cirrhosis after curative treatment of hepatocellular carcinoma [J]. World J Gastroenterol, 2007, 13(39): 51885195.
|
7. |
Lo CM, Hu CL, Chan SC, et al. A randomized controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma [J]. Ann Surg, 2007, 245(6): 831842..
|
8. |
Dawson LA, Eccles C, Bissonnette JP, et al. Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control [J]. Int J Radiat Oncol Biol Phys, 2005, 62(4): 12471252.
|
9. |
吳孟超. 中醫藥在肝癌防治中的作用、地位和存在的問題 [J]. 中西醫結合學報, 2003, 1(3): 163164.
|
10. |
Mizuta T, Ozaki I, Eguchi Y, et al. The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study [J]. Cancer, 2006, 106(4): 867872.
|
11. |
李瑜元. 原發性肝癌的非手術治療 [J]. 實用醫學雜志, 2003, 19(3): 231233..
|
12. |
樊嘉, 黃成. 原發性肝癌外科治療的進展 [J]. 中國普外基礎與臨床雜志, 2009, 16(4): 257260.
|
13. |
Ueno S, Kubo F, Sakoda M, et al. Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification [J]. J Hepatobiliary Pancreat Surg, 2008, 15(5): 493500.
|
14. |
Adam R, Del Gaudio M. Evolution of liver transplantation for hepatocellular carcinoma [J]. J Hepatol, 2003, 39(6): 888895.
|
15. |
Sugawara Y, Kokudo N. Surgical treatment of hepatocellular carcinoma: comparison of resection and transplantation [J]. Oncology, 2008, 75 Suppl 1: 119123.
|
16. |
楊廣順, 吳志全, 吳孟超. 原發性肝癌的規范化綜合治療 [J]. 中華外科雜志, 2001, 39(10): 742744.
|
17. |
Seo DD, Lee HC, Jang MK, et al. Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization [J]. Ann Surg Oncol, 2007, 14(12): 35013509.
|
18. |
Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a metaanalysis [J]. Ann Surg, 2008, 247(1): 4957.
|
19. |
Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study [J]. Radiology, 2003, 226(2): 441451.
|
20. |
姚和瑞, 謝德榮, 滕虹, 等. 高強度聚焦超聲熱療治療晚期原發性肝癌療效觀察 [J]. 新醫學, 2003, 34(5): 303304.
|
21. |
Lee J, Park JO, Kim WS, et al. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma [J]. Cancer Chemother Pharmacol, 2004, 54(5): 385390.
|
22. |
Ikeda M, Okusaka T, Ueno H, et al. A phase II trial of continuous infusion of 5fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma [J]. Cancer, 2005, 103(4): 756762.
|
23. |
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma [J]. Lancet, 2003, 362(9399): 19071917.
|